Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Crook

Showing results (61-70 of 259) with videos related to

Pageof 26
Sort By:
The Journal of Reproductive Medicine|March 1, 1991
Coronary heart disease risk markers in users of low-dose oral contraceptivesI F Godsland, D Crook, V Wynn
American Journal of Obstetrics and Gynecology|July 1, 1990
Low-dose oral contraceptives and carbohydrate metabolismI F Godsland, D Crook, V Wynn
Toxicology Letters|May 1, 1980
Quantitative aspects of spermatogenesis in rats and dogs after repeated hexachlorophene treatmentR W James, R Heywood, D Crook
Nature|February 29, 1996
Prescribing oral contraceptivesI F Godsland, D Crook, V Wynn
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 23, 2003
Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complicationsErrol D Crook, Lori Genous, Bonnie Oliver
Climacteric : the Journal of the International Menopause Society|April 5, 2005
Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature reviewD L Buick, D Crook, R Horne
American Journal of Obstetrics and Gynecology|June 1, 1992
Clinical and metabolic considerations of long-term oral contraceptive useI F Godsland, D Crook, V Wynn
BMJ (Clinical Research Ed.)|May 6, 1989
HDL as an independent risk factor in British men (and women)D Crook, I F Godsland, V Wynn
Fetal Therapy|January 1, 1988
Investigation of hypertriglyceridemia in small for gestational age fetusesD L Economides, D Crook, K H Nicolaides
Nature|March 7, 1985
Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbitN E Miller, A La Ville, D Crook
Pageof 26

Showing results (61-70 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Reproductive Medicine|March 1, 1991
Coronary heart disease risk markers in users of low-dose oral contraceptivesI F Godsland, D Crook, V Wynn
American Journal of Obstetrics and Gynecology|July 1, 1990
Low-dose oral contraceptives and carbohydrate metabolismI F Godsland, D Crook, V Wynn
Toxicology Letters|May 1, 1980
Quantitative aspects of spermatogenesis in rats and dogs after repeated hexachlorophene treatmentR W James, R Heywood, D Crook
Nature|February 29, 1996
Prescribing oral contraceptivesI F Godsland, D Crook, V Wynn
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|December 23, 2003
Angiotensin-converting enzyme genotype in blacks with diabetic nephropathy: effects on risk of diabetes and its complicationsErrol D Crook, Lori Genous, Bonnie Oliver
Climacteric : the Journal of the International Menopause Society|April 5, 2005
Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature reviewD L Buick, D Crook, R Horne
American Journal of Obstetrics and Gynecology|June 1, 1992
Clinical and metabolic considerations of long-term oral contraceptive useI F Godsland, D Crook, V Wynn
BMJ (Clinical Research Ed.)|May 6, 1989
HDL as an independent risk factor in British men (and women)D Crook, I F Godsland, V Wynn
Fetal Therapy|January 1, 1988
Investigation of hypertriglyceridemia in small for gestational age fetusesD L Economides, D Crook, K H Nicolaides
Nature|March 7, 1985
Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbitN E Miller, A La Ville, D Crook
Pageof 26